Iniciar sesión Regístrese gratis

AMAG Pharmaceuticals Ingresos Q/Q

¿Qué es el Ingresos Q/Q de AMAG Pharmaceuticals?

El Ingresos Q/Q de AMAG Pharmaceuticals, Inc. es 10.67%

¿Cuál es la definición de Ingresos Q/Q?

El crecimiento de los ingresos trimestrales, año tras año, es el aumento de los ingresos de una empresa en comparación con el compiortamiento en el trimestre correspondiente de un año anterior expresado como un porcentaje.

Quaterly revenue growth is the amount by which revenue exceeds the revenue in a previous quarter. It is beneficial to look at a company's quarterly financials to identify how the company is performing over time not just during the current period. The usage of year over year comparison is advantageous in removing seasonalities in reporting the quarterly revenue growth and observing longterm trends.

Ingresos Q/Q de compañías en Sector Health Care en NASDAQ en comparadas con AMAG Pharmaceuticals

¿Qué hace AMAG Pharmaceuticals?

AMAG Pharmaceuticals, Inc. is a biopharmaceutical company. It focuses on the manufacture, development, and commercialization of a therapeutic iron compound to treat iron deficiency anemia. The firm focuses on the development and commercialization of Feraheme injection for intravenous use to treat iron deficiency anemia. It manufactures, develops, and commercializes products derived from its proprietary technology for use in treating human diseases. Its products include Intrarosa, Vyleesi, Makena, CBR, Feraheme, and MuGard. The company was founded on November 9, 1981 and is headquartered in Waltham, MA.

Empresas con ingresos q/q similar a AMAG Pharmaceuticals